EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Farnesyltransferase inhibitors decrease matrix-vesicle-mediated mineralization in SaOS-2 cells

Tim Bürgel, Daniel Diehl, Elisabeth-Cosima van Lier, Anton Friedmann, Anna Hagemann, Hagen S Bachmann

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-025-11138-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Tim Bürgel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, Centre for Biomedical Education and Research, Witten/Herdecke University, Witten, Germany. Hauptthemen laut MEDLINE: Farnesyltranstransferase, Calcification, Physiologic, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Private Universität Witten/Herdecke gGmbH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Farnesyltransferase inhibitors (FTIs) were developed for preventing the prenylation of aberrant Ras in human cancer. Furthermore, prenylation is involved in multiple biological processes and plays a putative role in signalling pathways such as the Ras-mitogen-activated-protein kinase (MAPK) pathway. Matrix-vesicle-mediated mineralization (MVM) is the first step in the development of eukaryotic mineralized tissue. In this study, we evaluated the effect of FTIs on MVM in the osteosarcoma cell line SaOS-2 and elucidated the role of farnesylation in this process.

Methods

SaOS-2 cells were treated with the FTIs Lonafarnib and Tipifarnib. Mineralization was assessed using Alizarin Red S staining. Enzyme assays were conducted to measure alkaline phosphatase (ALP) activity. Western blot analysis and Oxford Nanopore sequencing were performed to evaluate the expression of ALP, collagen type I (COL1A1), and Runt-related transcription factor 2 (RUNX2).

Results

Inhibition of farnesylation by FTIs resulted in decreased mineralization, as evidenced by reduced Alizarin Red S staining. Additionally, RUNX2 activity was diminished, leading to a reduction in MVM and decreased expression of ALP and COL1A1.

Conclusion

Our findings demonstrate that FTIs Lonafarnib and Tipifarnib impair MVM, highlighting the essential role of farnesylation in biomineralization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FarnesyltranstransferaseCalcification, PhysiologicEnzyme InhibitorsHumansCell Line, TumorQuinolonesPyridinesPiperidinesCore Binding Factor Alpha 1 SubunitOsteosarcomaAlkaline PhosphataseCollagen Type IDibenzocycloheptenes

Stichwörter der Autor:innen

FarnesyltransferaseLonafarnibMineralizationOsteosarcomaPrenylationTipifarnib

Substanzen

FarnesyltranstransferaseQuinolonestipifarniblonafarnibEnzyme InhibitorsPyridinesPiperidinesCore Binding Factor Alpha 1 SubunitAlkaline PhosphataseRUNX2 protein, human

Autor:innen und Institutionen

  • Institute of Pharmacology and Toxicology, Centre for Biomedical Education and Research, Witten/Herdecke University, Witten, Germany.
  • Department of Periodontology, Centre for Biomedical Education and Research, Witten/Herdecke University, Witten, Germany.
  • Institute of Pharmacology and Toxicology, Centre for Biomedical Education and Research, Witten/Herdecke University, Witten, Germany. hagen.bachmann@uni-wh.de.

Förderung

  • Private Universität Witten/Herdecke gGmbH

Zitieren

APA

Bürgel, T., Diehl, D., van Lier, E. C., Friedmann, A., Hagemann, A., & Bachmann, H. S. (2026). Farnesyltransferase inhibitors decrease matrix-vesicle-mediated mineralization in SaOS-2 cells. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11138-2

Vancouver

Bürgel T, Diehl D, van Lier EC, Friedmann A, Hagemann A, Bachmann HS. Farnesyltransferase inhibitors decrease matrix-vesicle-mediated mineralization in SaOS-2 cells. Molecular Biology Reports. 2026. doi:10.1007/s11033-025-11138-2

BibTeX
@article{Brgel2026,
  author = {Bürgel, Tim and Diehl, Daniel and van Lier, Elisabeth-Cosima and Friedmann, Anton and Hagemann, Anna and Bachmann, Hagen S},
  title = {Farnesyltransferase inhibitors decrease matrix-vesicle-mediated mineralization in SaOS-2 cells},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-025-11138-2}
}
Kostenlos starten →